Christian S Hendershot

Nov 24, 2023 | nature.com | Lorenzo Leggio |Christian S Hendershot |Mehdi Farokhnia |Anders Fink-Jensen |Mette Kruse Klausen

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.